Present situation of genital tract infection in gonorrhea patients and standardized treatment.

YANG Han; XU Chun-lin.

doi:10.7504/fk2014080103

PDF(973 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (9) : 662-666. DOI: 10.7504/fk2014080103

Present situation of genital tract infection in gonorrhea patients and standardized treatment.

YANG Han,XU Chun-lin.

Author information +

History +

Abstract

Abstract: Gonorrhea is a purulent disease of genitourinary system,which is caused by Neisseria gonorrhoeae.Gonorrhea is a major cause of serious reproductive complications,such as pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy and tubal infertility.Therefore, it is important for us to fully understand gonorrhea,and to grasp the epidemiological characteristics and the standard treatment.

Key words

gonorhea / Neisseria gonorrhoeae / standardized treatment / drug resistance

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YANG Han,XU Chun-lin.. Present situation of genital tract infection in gonorrhea patients and standardized treatment.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2014, 30(9): 662-666 https://doi.org/10.7504/fk2014080103

References

［1］    Ohnishi M, Saika T, Hoshina S,et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan［J］. Emerg Infect Dis,2011,17(1): 148-149.

［2］    World Health Organization, UNAIDS, UNICEF. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access［R］. Progress report 2011. Geneva, Switzerland: World Health Organization,2011:p56.

［3］    Workowski KA,Berman S,Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010［J］.MMWR, 2010,59 (RR-12):49-55.

［4］    Martin I,Sawatzky P,Liu G,et al .Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010［J］.Can J Microbiol,2013,59(10):671-678.

［5］    Jakopanec I,Borgen K,Aavitsland P.The epidemiology of gonorrhoea in Norway, 1993–2007: past victories, future challenges［J］.BMC Infecti Dis,2009,9:33.

［6］    Australian Government Department of Health. National Notifiable Diseases Surveillance System dataset. Accessed in 2013.Available from: http://www9.health.gov.au/cda/source/cda-index.cfm

［7］    Nsuami M,Cammarata CL,Brooks BN,et al.Chlamydia and gonorrhea co-occurrence in a high school population［J］.Sex Transm Dis,2004,31(7):424-427.

［8］    Saidel T, Adhikary R, Mainkar M,et al.Baseline integrated behavioural and biological assessment among most at-risk populations in six high-prevalence states of India: design and implementation challenges［J］.AIDS,2008,22 (Suppl 5):S17-34.

［9］    范国雄,陈伟梅.惠州市女性性服务者性病感染情况的流行病学研究［J］.中国实用医药,2013,8(23): 260-261.

［10］    Das A,Pathni AK,Narayanan P,et al.High rates of reinfection and incidence of bacterial sexually transmitted infections in a cohort of female sex workers from two Indian cities: need for different STI control strategies?［J］.Sex Transm Infect,2013,89(1):5-10.

［11］    Hammerschlag MR.Chlamydial and gonococcal infections in infants and children［J］.Clin Infect Dis,2011,53(Suppl 3):S99-102.

［12］   Anschuetz GL,Asbel L,Spain CV,et al.Association between enhanced screening for chlamydia trachomatis and Neisseria gonorrhoeae and reductions in sequelae among women［J］.J Adolesc Health,2012,51(1):80-85.

［13］    Centers for Disease Control and Prevention (CDC).Cephalosporin susceptibility among Neisseria gonorrhoeae Isolates-United States,2000-2010［J］. MMWR,2011,60(26):873-877.

［14］    吴兴中,黄进梅,刘小凤，等.广东省5市525株淋球菌临床分离株耐药性的流行病学研究［J］.皮肤性病诊疗学杂志,2013,20(6):396-400.

［15］    董玉军,关海军.淋球菌耐药性及淋病治疗分析［J］.中国实用医药,2011,5(35):130-131.

［16］    黄忠强.新生儿淋球菌性结膜炎96例药敏结果分析［J］.淮海医药,2010,28(4):335-336.

［17］   U.S. Preventive Services Task Force. Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement［J］. Am Fam Physician,2012,85(2):195-196.

［18］    沈颖,蔡绥勃.小儿淋病51例回顾性分析［J］.中国皮肤性病学杂志,2011,25(6):457-458.

（2014-05-17收稿）